Results of different clinical studies:
MRC AML 10 Outcome
Remission induction rate 83%
Five year event free survival 50%
CCG-2891 Outcome (Eight year survival)
Allogeneic BMT – 60%
Autologous BMT – 48%
Chemotherapy only – 53%
CCG-2961 Outcome (Five year survival)
Overall survival – 52%
Event free survival – 42%
